ampicillin has been researched along with paclitaxel in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fan, JT; Ji, CJ; Kuang, B; Tan, NH; Zeng, GZ; Zhang, YM; Zhao, SM | 1 |
| Han, J; He, WJ; Ji, CJ; Tan, NH; Zeng, GZ; Zhang, YM | 1 |
| Açık, L; Akbaş, H; Celik, ZB; Hökelek, T; Kılıç, Z; Koç, LY; Okumuş, A; Süzen, Y | 1 |
| Alankuş-Çalışkan, Ö; Çapcı-Karagöz, A; Emirdağ-Öztürk, S; Karayıldırım, T; Özmen, A; Poyrazoğlu-Çoban, E | 1 |
| Bhatt, K; Desai, NC; Jha, PC; Khedkar, VM; Nawale, L; Sarkar, D; Somani, H; Trivedi, A | 1 |
| Arkile, MA; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Khan, FA; Nawale, L; Sangshetti, JN; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
| Kalam Khan, FA; Khedkar, VM; Nawale, L; Sangshetti, JN; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD | 1 |
| Bhalerao, MB; Deshmukh, AR; Dhumal, ST; Khedkar, V; Mane, RA; Nawale, LU; Sarkar, D | 1 |
| Khedkar, VM; Nawale, L; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD | 1 |
| Abhale, YK; Bhansali, S; Chavan, AP; Deshmukh, KK; Mhaske, PC; Nawale, L; Sarkar, D; Sasane, AV; Shekh, SH | 1 |
| Abdel-Maksoud, MS; Ali, EMH; Oh, CH | 1 |
2 review(s) available for ampicillin and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemistry, Pharmaceutical; Humans; Inflammation; Neoplasms; Pyrimidines; Structure-Activity Relationship | 2019 |
16 other study(ies) available for ampicillin and paclitaxel
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biologically active arborinane-type triterpenoids and anthraquinones from Rubia yunnanensis.
Topics: Anthraquinones; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Candida albicans; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Plant Roots; Rubia; Staphylococcus aureus; Structure-Activity Relationship; Triterpenes | 2011 |
Zizimauritic acids A-C, three novel nortriterpenes from Ziziphus mauritiana.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Neoplasms; Plant Roots; Staphylococcal Infections; Staphylococcus aureus; Triterpenes; Ziziphus | 2012 |
Phosphorus-nitrogen compounds part 27. Syntheses, structural characterizations, antimicrobial and cytotoxic activities, and DNA interactions of new phosphazenes bearing secondary amino and pendant (4-fluorobenzyl)spiro groups.
Topics: Amines; Antifungal Agents; Antineoplastic Agents; Apoptosis; Candida; Cell Proliferation; Cell Survival; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Models, Molecular; Molecular Structure; Organophosphorus Compounds; Plasmids; Spiro Compounds; Structure-Activity Relationship | 2013 |
Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacillus; Caco-2 Cells; Candida; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; HL-60 Cells; HT29 Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Conformation; Saponins; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis | 2016 |
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Combinatorial Chemistry Techniques; Green Chemistry Technology; Humans; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidines; Tuberculosis | 2016 |
Novel tetrazoloquinoline-rhodanine conjugates: Highly efficient synthesis and biological evaluation.
Topics: Quinolines; Rhodanine | 2016 |
Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Line; Humans; Metalloproteases; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium Infections; Mycobacterium tuberculosis; Quinolines; Rhodanine | 2017 |
New bithiazolyl hydrazones: Novel synthesis, characterization and antitubercular evaluation.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Hydrazones; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium; Mycobacterium bovis; Structure-Activity Relationship; Thiazoles | 2017 |
Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
Topics: Antitubercular Agents; Cell Line, Tumor; Curcumin; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Quinolines | 2017 |
Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cell Line; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium; Oxazoles; Thiazoles | 2017 |